A Multi-Center Retrospective Study to Describe Clinical Characteristics and Outcomes of Early EVENITY Users, Transitioning to Antiresorptive Agents in Japan - A Multi-Center Retrospective Study to Describe Clinical Characteristics and Outcomes of Early EVENITY Users, Transitioning to Antiresorptive Agents in Japan

There was a total of 1027 patients in this study of which >=90% were female. The mean age at the initiation of EVENITY for all patients was 77.0 years. A percentage of 54.9% of patients had previous OP medications within 6 months before EVENITY initiation. At 12 and 18 months of treatment, the mean percent change in BMD from baseline was 13.4% and 13.8% for the LS, 4.0% and 4.8% for TH, and 3.6% and 4.5% for FN in the FAS.